nodes	percent_of_prediction	percent_of_DWPC	metapath
Albendazole—ABCB1—ulcerative colitis	0.349	1	CbGaD
Albendazole—CYP1A1—Nicotine—ulcerative colitis	0.0827	0.157	CbGbCtD
Albendazole—CYP1A1—Cholecalciferol—ulcerative colitis	0.0742	0.14	CbGbCtD
Albendazole—CYP3A4—Budesonide—ulcerative colitis	0.0445	0.0842	CbGbCtD
Albendazole—CYP1A2—Nicotine—ulcerative colitis	0.0369	0.07	CbGbCtD
Albendazole—ABCB1—Methylprednisolone—ulcerative colitis	0.0331	0.0628	CbGbCtD
Albendazole—CYP1A1—Dexamethasone—ulcerative colitis	0.0321	0.0608	CbGbCtD
Albendazole—ABCB1—Betamethasone—ulcerative colitis	0.0216	0.0408	CbGbCtD
Albendazole—ABCB1—Prednisolone—ulcerative colitis	0.0213	0.0403	CbGbCtD
Albendazole—ABCB1—Hydrocortisone—ulcerative colitis	0.0202	0.0382	CbGbCtD
Albendazole—ABCB1—Prednisone—ulcerative colitis	0.0201	0.038	CbGbCtD
Albendazole—CYP3A4—Methylprednisolone—ulcerative colitis	0.0199	0.0376	CbGbCtD
Albendazole—CYP3A4—Nicotine—ulcerative colitis	0.0194	0.0367	CbGbCtD
Albendazole—CYP3A4—Cholecalciferol—ulcerative colitis	0.0174	0.0329	CbGbCtD
Albendazole—CYP3A4—Triamcinolone—ulcerative colitis	0.0151	0.0285	CbGbCtD
Albendazole—CYP3A4—Betamethasone—ulcerative colitis	0.0129	0.0245	CbGbCtD
Albendazole—CYP3A4—Prednisolone—ulcerative colitis	0.0127	0.0241	CbGbCtD
Albendazole—ABCB1—Dexamethasone—ulcerative colitis	0.0125	0.0237	CbGbCtD
Albendazole—CYP3A4—Hydrocortisone—ulcerative colitis	0.0121	0.0229	CbGbCtD
Albendazole—CYP3A4—Prednisone—ulcerative colitis	0.012	0.0228	CbGbCtD
Albendazole—CYP3A4—Dexamethasone—ulcerative colitis	0.00751	0.0142	CbGbCtD
Albendazole—Alopecia reversible—Mesalazine—ulcerative colitis	0.00487	0.058	CcSEcCtD
Albendazole—TUBA1A—Loss of Nlp from mitotic centrosomes—CEP72—ulcerative colitis	0.00222	0.0711	CbGpPWpGaD
Albendazole—TUBA1A—Centrosome maturation—CEP72—ulcerative colitis	0.00196	0.063	CbGpPWpGaD
Albendazole—Intracranial pressure increased—Prednisolone—ulcerative colitis	0.00193	0.023	CcSEcCtD
Albendazole—Intracranial pressure increased—Hydrocortisone—ulcerative colitis	0.00188	0.0224	CcSEcCtD
Albendazole—TUBA1A—Pathogenic Escherichia coli infection—ARPC2—ulcerative colitis	0.00188	0.0603	CbGpPWpGaD
Albendazole—TUBA1A—Regulation of PLK1 Activity at G2/M Transition—CEP72—ulcerative colitis	0.0018	0.0578	CbGpPWpGaD
Albendazole—Intracranial pressure increased—Triamcinolone—ulcerative colitis	0.00177	0.0211	CcSEcCtD
Albendazole—Intracranial pressure increased—Methylprednisolone—ulcerative colitis	0.00177	0.0211	CcSEcCtD
Albendazole—Intracranial pressure increased—Betamethasone—ulcerative colitis	0.00161	0.0192	CcSEcCtD
Albendazole—Intracranial pressure increased—Dexamethasone—ulcerative colitis	0.00161	0.0192	CcSEcCtD
Albendazole—Intracranial pressure increased—Prednisone—ulcerative colitis	0.0014	0.0167	CcSEcCtD
Albendazole—TUBA1A—G2/M Transition—CEP72—ulcerative colitis	0.00135	0.0434	CbGpPWpGaD
Albendazole—TUBB4B—Loss of Nlp from mitotic centrosomes—CEP72—ulcerative colitis	0.00134	0.0429	CbGpPWpGaD
Albendazole—TUBA1A—Mitotic G2-G2/M phases—CEP72—ulcerative colitis	0.00134	0.0428	CbGpPWpGaD
Albendazole—Pancytopenia—Mercaptopurine—ulcerative colitis	0.00121	0.0145	CcSEcCtD
Albendazole—TUBB4B—Centrosome maturation—CEP72—ulcerative colitis	0.00119	0.038	CbGpPWpGaD
Albendazole—Aplastic anaemia—Azathioprine—ulcerative colitis	0.00114	0.0136	CcSEcCtD
Albendazole—TUBB4B—Pathogenic Escherichia coli infection—ARPC2—ulcerative colitis	0.00114	0.0364	CbGpPWpGaD
Albendazole—TUBB4B—Regulation of PLK1 Activity at G2/M Transition—CEP72—ulcerative colitis	0.00109	0.0349	CbGpPWpGaD
Albendazole—Hepatobiliary disease—Mercaptopurine—ulcerative colitis	0.00108	0.0128	CcSEcCtD
Albendazole—Aplastic anaemia—Mesalazine—ulcerative colitis	0.00104	0.0124	CcSEcCtD
Albendazole—Immune system disorder—Mercaptopurine—ulcerative colitis	0.000924	0.011	CcSEcCtD
Albendazole—Alopecia—Mercaptopurine—ulcerative colitis	0.000904	0.0108	CcSEcCtD
Albendazole—Immune system disorder—Nicotine—ulcerative colitis	0.000895	0.0107	CcSEcCtD
Albendazole—Renal failure acute—Mesalazine—ulcerative colitis	0.000869	0.0104	CcSEcCtD
Albendazole—TUBA1A—epithelium—ulcerative colitis	0.000863	0.119	CbGeAlD
Albendazole—TUBA1A—smooth muscle tissue—ulcerative colitis	0.000832	0.114	CbGeAlD
Albendazole—TUBB4B—G2/M Transition—CEP72—ulcerative colitis	0.000818	0.0262	CbGpPWpGaD
Albendazole—TUBB4B—Mitotic G2-G2/M phases—CEP72—ulcerative colitis	0.000807	0.0259	CbGpPWpGaD
Albendazole—Leukopenia—Mercaptopurine—ulcerative colitis	0.000797	0.00949	CcSEcCtD
Albendazole—Vertigo—Nicotine—ulcerative colitis	0.000775	0.00923	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—ulcerative colitis	0.000753	0.00897	CcSEcCtD
Albendazole—Liver function test abnormal—Mesalazine—ulcerative colitis	0.000741	0.00883	CcSEcCtD
Albendazole—Mebendazole—ABCB1—ulcerative colitis	0.000741	1	CrCbGaD
Albendazole—TUBA1A—Pathogenic Escherichia coli infection—CD14—ulcerative colitis	0.000727	0.0233	CbGpPWpGaD
Albendazole—Pancytopenia—Azathioprine—ulcerative colitis	0.000723	0.00861	CcSEcCtD
Albendazole—Thrombocytopenia—Mercaptopurine—ulcerative colitis	0.000712	0.00848	CcSEcCtD
Albendazole—Skin disorder—Mercaptopurine—ulcerative colitis	0.000706	0.00841	CcSEcCtD
Albendazole—Urinary tract disorder—Budesonide—ulcerative colitis	0.000674	0.00803	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Azathioprine—ulcerative colitis	0.000673	0.00802	CcSEcCtD
Albendazole—Urethral disorder—Budesonide—ulcerative colitis	0.000669	0.00797	CcSEcCtD
Albendazole—TUBA1A—lymphoid tissue—ulcerative colitis	0.000665	0.0913	CbGeAlD
Albendazole—Pancytopenia—Mesalazine—ulcerative colitis	0.000659	0.00785	CcSEcCtD
Albendazole—TUBA1A—digestive system—ulcerative colitis	0.000657	0.0902	CbGeAlD
Albendazole—Neutropenia—Mesalazine—ulcerative colitis	0.000649	0.00773	CcSEcCtD
Albendazole—Hepatobiliary disease—Azathioprine—ulcerative colitis	0.000642	0.00765	CcSEcCtD
Albendazole—Agranulocytosis—Azathioprine—ulcerative colitis	0.000634	0.00755	CcSEcCtD
Albendazole—Immune system disorder—Budesonide—ulcerative colitis	0.000617	0.00734	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Mesalazine—ulcerative colitis	0.000613	0.0073	CcSEcCtD
Albendazole—Alopecia—Budesonide—ulcerative colitis	0.000603	0.00719	CcSEcCtD
Albendazole—Hepatobiliary disease—Mesalazine—ulcerative colitis	0.000585	0.00697	CcSEcCtD
Albendazole—Agranulocytosis—Mesalazine—ulcerative colitis	0.000577	0.00687	CcSEcCtD
Albendazole—Erythema multiforme—Azathioprine—ulcerative colitis	0.000576	0.00686	CcSEcCtD
Albendazole—Gastrointestinal pain—Nicotine—ulcerative colitis	0.000576	0.00686	CcSEcCtD
Albendazole—Body temperature increased—Mercaptopurine—ulcerative colitis	0.000575	0.00684	CcSEcCtD
Albendazole—Urticaria—Nicotine—ulcerative colitis	0.000559	0.00666	CcSEcCtD
Albendazole—Abdominal pain—Nicotine—ulcerative colitis	0.000557	0.00663	CcSEcCtD
Albendazole—Body temperature increased—Nicotine—ulcerative colitis	0.000557	0.00663	CcSEcCtD
Albendazole—Hepatitis—Mesalazine—ulcerative colitis	0.000555	0.00661	CcSEcCtD
Albendazole—TUBB4B—smooth muscle tissue—ulcerative colitis	0.000555	0.0761	CbGeAlD
Albendazole—Immune system disorder—Azathioprine—ulcerative colitis	0.000551	0.00656	CcSEcCtD
Albendazole—Urinary tract disorder—Mesalazine—ulcerative colitis	0.000548	0.00653	CcSEcCtD
Albendazole—Urethral disorder—Mesalazine—ulcerative colitis	0.000544	0.00648	CcSEcCtD
Albendazole—Alopecia—Azathioprine—ulcerative colitis	0.000539	0.00642	CcSEcCtD
Albendazole—Hypersensitivity—Mercaptopurine—ulcerative colitis	0.000535	0.00638	CcSEcCtD
Albendazole—Vertigo—Budesonide—ulcerative colitis	0.000534	0.00636	CcSEcCtD
Albendazole—Erythema multiforme—Mesalazine—ulcerative colitis	0.000525	0.00625	CcSEcCtD
Albendazole—Hypersensitivity—Nicotine—ulcerative colitis	0.000519	0.00618	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Budesonide—ulcerative colitis	0.000502	0.00598	CcSEcCtD
Albendazole—Immune system disorder—Mesalazine—ulcerative colitis	0.000502	0.00597	CcSEcCtD
Albendazole—TUBA1A—Pathogenic Escherichia coli infection—TLR4—ulcerative colitis	0.000498	0.016	CbGpPWpGaD
Albendazole—Alopecia—Mesalazine—ulcerative colitis	0.000491	0.00584	CcSEcCtD
Albendazole—TUBA1A—liver—ulcerative colitis	0.000489	0.0672	CbGeAlD
Albendazole—Leukopenia—Azathioprine—ulcerative colitis	0.000475	0.00566	CcSEcCtD
Albendazole—Skin disorder—Budesonide—ulcerative colitis	0.000471	0.00561	CcSEcCtD
Albendazole—Dizziness—Nicotine—ulcerative colitis	0.000466	0.00555	CcSEcCtD
Albendazole—ABCB1—Allograft Rejection—MICA—ulcerative colitis	0.000465	0.0149	CbGpPWpGaD
Albendazole—Vomiting—Mercaptopurine—ulcerative colitis	0.000462	0.0055	CcSEcCtD
Albendazole—Rash—Mercaptopurine—ulcerative colitis	0.000458	0.00546	CcSEcCtD
Albendazole—Dermatitis—Mercaptopurine—ulcerative colitis	0.000458	0.00545	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—ulcerative colitis	0.000449	0.00534	CcSEcCtD
Albendazole—Vomiting—Nicotine—ulcerative colitis	0.000448	0.00533	CcSEcCtD
Albendazole—Rash—Nicotine—ulcerative colitis	0.000444	0.00529	CcSEcCtD
Albendazole—Dermatitis—Nicotine—ulcerative colitis	0.000444	0.00528	CcSEcCtD
Albendazole—TUBB4B—lymphoid tissue—ulcerative colitis	0.000443	0.0609	CbGeAlD
Albendazole—Headache—Nicotine—ulcerative colitis	0.000441	0.00525	CcSEcCtD
Albendazole—TUBB4B—Pathogenic Escherichia coli infection—CD14—ulcerative colitis	0.000439	0.0141	CbGpPWpGaD
Albendazole—TUBB4B—digestive system—ulcerative colitis	0.000438	0.0601	CbGeAlD
Albendazole—Vertigo—Mesalazine—ulcerative colitis	0.000434	0.00517	CcSEcCtD
Albendazole—Leukopenia—Mesalazine—ulcerative colitis	0.000433	0.00515	CcSEcCtD
Albendazole—Nausea—Mercaptopurine—ulcerative colitis	0.000432	0.00514	CcSEcCtD
Albendazole—TUBA1A—Cell Cycle, Mitotic—CEP72—ulcerative colitis	0.000431	0.0138	CbGpPWpGaD
Albendazole—Thrombocytopenia—Azathioprine—ulcerative colitis	0.000424	0.00505	CcSEcCtD
Albendazole—TUBA1A—Pathogenic Escherichia coli infection—CDH1—ulcerative colitis	0.000423	0.0135	CbGpPWpGaD
Albendazole—Skin disorder—Azathioprine—ulcerative colitis	0.000421	0.00501	CcSEcCtD
Albendazole—Nausea—Nicotine—ulcerative colitis	0.000418	0.00498	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—ulcerative colitis	0.000409	0.00487	CcSEcCtD
Albendazole—Gastrointestinal pain—Budesonide—ulcerative colitis	0.000397	0.00472	CcSEcCtD
Albendazole—Thrombocytopenia—Mesalazine—ulcerative colitis	0.000386	0.0046	CcSEcCtD
Albendazole—TUBA1A—Cell Cycle—CEP72—ulcerative colitis	0.000385	0.0124	CbGpPWpGaD
Albendazole—Urticaria—Budesonide—ulcerative colitis	0.000385	0.00459	CcSEcCtD
Albendazole—Body temperature increased—Budesonide—ulcerative colitis	0.000383	0.00457	CcSEcCtD
Albendazole—Abdominal pain—Budesonide—ulcerative colitis	0.000383	0.00457	CcSEcCtD
Albendazole—Skin disorder—Mesalazine—ulcerative colitis	0.000383	0.00456	CcSEcCtD
Albendazole—TUBA1A—Metabolism of proteins—MUC3A—ulcerative colitis	0.000368	0.0118	CbGpPWpGaD
Albendazole—Hypersensitivity—Budesonide—ulcerative colitis	0.000357	0.00426	CcSEcCtD
Albendazole—Immune system disorder—Hydrocortisone—ulcerative colitis	0.000357	0.00425	CcSEcCtD
Albendazole—Gastrointestinal pain—Azathioprine—ulcerative colitis	0.000354	0.00422	CcSEcCtD
Albendazole—Neutropenia—Prednisone—ulcerative colitis	0.000343	0.00409	CcSEcCtD
Albendazole—Body temperature increased—Azathioprine—ulcerative colitis	0.000342	0.00408	CcSEcCtD
Albendazole—Abdominal pain—Azathioprine—ulcerative colitis	0.000342	0.00408	CcSEcCtD
Albendazole—CYP3A4—Codeine and Morphine Metabolism—ABCB1—ulcerative colitis	0.000337	0.0108	CbGpPWpGaD
Albendazole—Immune system disorder—Methylprednisolone—ulcerative colitis	0.000335	0.00399	CcSEcCtD
Albendazole—TUBB4B—liver—ulcerative colitis	0.000326	0.0448	CbGeAlD
Albendazole—Gastrointestinal pain—Mesalazine—ulcerative colitis	0.000323	0.00384	CcSEcCtD
Albendazole—CYP1A1—epithelium—ulcerative colitis	0.000322	0.0442	CbGeAlD
Albendazole—Dizziness—Budesonide—ulcerative colitis	0.000321	0.00382	CcSEcCtD
Albendazole—Hypersensitivity—Azathioprine—ulcerative colitis	0.000319	0.0038	CcSEcCtD
Albendazole—Vertigo—Prednisolone—ulcerative colitis	0.000316	0.00377	CcSEcCtD
Albendazole—Urticaria—Mesalazine—ulcerative colitis	0.000313	0.00373	CcSEcCtD
Albendazole—Abdominal pain—Mesalazine—ulcerative colitis	0.000312	0.00371	CcSEcCtD
Albendazole—Body temperature increased—Mesalazine—ulcerative colitis	0.000312	0.00371	CcSEcCtD
Albendazole—Vertigo—Hydrocortisone—ulcerative colitis	0.000309	0.00368	CcSEcCtD
Albendazole—Vomiting—Budesonide—ulcerative colitis	0.000308	0.00367	CcSEcCtD
Albendazole—Rash—Budesonide—ulcerative colitis	0.000306	0.00364	CcSEcCtD
Albendazole—Dermatitis—Budesonide—ulcerative colitis	0.000306	0.00364	CcSEcCtD
Albendazole—Headache—Budesonide—ulcerative colitis	0.000304	0.00362	CcSEcCtD
Albendazole—TUBB4B—Pathogenic Escherichia coli infection—TLR4—ulcerative colitis	0.000301	0.00965	CbGpPWpGaD
Albendazole—ABCB1—Drug Induction of Bile Acid Pathway—VDR—ulcerative colitis	0.000298	0.00956	CbGpPWpGaD
Albendazole—Alopecia—Betamethasone—ulcerative colitis	0.000298	0.00355	CcSEcCtD
Albendazole—Alopecia—Dexamethasone—ulcerative colitis	0.000298	0.00355	CcSEcCtD
Albendazole—Vertigo—Triamcinolone—ulcerative colitis	0.000291	0.00346	CcSEcCtD
Albendazole—Hypersensitivity—Mesalazine—ulcerative colitis	0.000291	0.00346	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.000291	0.00346	CcSEcCtD
Albendazole—Vertigo—Methylprednisolone—ulcerative colitis	0.00029	0.00346	CcSEcCtD
Albendazole—Nausea—Budesonide—ulcerative colitis	0.000288	0.00343	CcSEcCtD
Albendazole—Dizziness—Azathioprine—ulcerative colitis	0.000286	0.00341	CcSEcCtD
Albendazole—Vomiting—Azathioprine—ulcerative colitis	0.000275	0.00328	CcSEcCtD
Albendazole—Rash—Azathioprine—ulcerative colitis	0.000273	0.00325	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000273	0.00325	CcSEcCtD
Albendazole—Dermatitis—Azathioprine—ulcerative colitis	0.000273	0.00325	CcSEcCtD
Albendazole—Skin disorder—Hydrocortisone—ulcerative colitis	0.000272	0.00325	CcSEcCtD
Albendazole—Headache—Azathioprine—ulcerative colitis	0.000271	0.00323	CcSEcCtD
Albendazole—TUBA1A—p73 transcription factor network—RELA—ulcerative colitis	0.000269	0.00861	CbGpPWpGaD
Albendazole—TUBB4B—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	0.000267	0.00856	CbGpPWpGaD
Albendazole—Immune system disorder—Prednisone—ulcerative colitis	0.000265	0.00316	CcSEcCtD
Albendazole—Vertigo—Dexamethasone—ulcerative colitis	0.000264	0.00314	CcSEcCtD
Albendazole—Vertigo—Betamethasone—ulcerative colitis	0.000264	0.00314	CcSEcCtD
Albendazole—Dizziness—Mesalazine—ulcerative colitis	0.000261	0.00311	CcSEcCtD
Albendazole—TUBB4B—Cell Cycle, Mitotic—CEP72—ulcerative colitis	0.00026	0.00834	CbGpPWpGaD
Albendazole—Alopecia—Prednisone—ulcerative colitis	0.00026	0.00309	CcSEcCtD
Albendazole—Nausea—Azathioprine—ulcerative colitis	0.000257	0.00306	CcSEcCtD
Albendazole—Skin disorder—Methylprednisolone—ulcerative colitis	0.000256	0.00305	CcSEcCtD
Albendazole—TUBB4B—Pathogenic Escherichia coli infection—CDH1—ulcerative colitis	0.000255	0.00818	CbGpPWpGaD
Albendazole—Vomiting—Mesalazine—ulcerative colitis	0.000251	0.00299	CcSEcCtD
Albendazole—Rash—Mesalazine—ulcerative colitis	0.000249	0.00296	CcSEcCtD
Albendazole—CYP1A2—digestive system—ulcerative colitis	0.000249	0.0341	CbGeAlD
Albendazole—Dermatitis—Mesalazine—ulcerative colitis	0.000248	0.00296	CcSEcCtD
Albendazole—Headache—Mesalazine—ulcerative colitis	0.000247	0.00294	CcSEcCtD
Albendazole—CYP1A1—digestive system—ulcerative colitis	0.000245	0.0337	CbGeAlD
Albendazole—Thrombocytopenia—Betamethasone—ulcerative colitis	0.000235	0.00279	CcSEcCtD
Albendazole—Thrombocytopenia—Dexamethasone—ulcerative colitis	0.000235	0.00279	CcSEcCtD
Albendazole—Nausea—Mesalazine—ulcerative colitis	0.000234	0.00279	CcSEcCtD
Albendazole—TUBB4B—Cell Cycle—CEP72—ulcerative colitis	0.000233	0.00746	CbGpPWpGaD
Albendazole—Vertigo—Prednisone—ulcerative colitis	0.00023	0.00274	CcSEcCtD
Albendazole—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	0.000229	0.00273	CcSEcCtD
Albendazole—Urticaria—Prednisolone—ulcerative colitis	0.000228	0.00272	CcSEcCtD
Albendazole—CYP1A1—Arachidonic acid metabolism—PTGS1—ulcerative colitis	0.000226	0.00723	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—ulcerative colitis	0.000224	0.00718	CbGpPWpGaD
Albendazole—Urticaria—Hydrocortisone—ulcerative colitis	0.000223	0.00265	CcSEcCtD
Albendazole—TUBB4B—Metabolism of proteins—MUC3A—ulcerative colitis	0.000222	0.00711	CbGpPWpGaD
Albendazole—Abdominal pain—Hydrocortisone—ulcerative colitis	0.000222	0.00264	CcSEcCtD
Albendazole—Body temperature increased—Hydrocortisone—ulcerative colitis	0.000222	0.00264	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.000216	0.00258	CcSEcCtD
Albendazole—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	0.000215	0.00257	CcSEcCtD
Albendazole—Hypersensitivity—Prednisolone—ulcerative colitis	0.000212	0.00252	CcSEcCtD
Albendazole—Urticaria—Triamcinolone—ulcerative colitis	0.00021	0.0025	CcSEcCtD
Albendazole—Urticaria—Methylprednisolone—ulcerative colitis	0.000209	0.00249	CcSEcCtD
Albendazole—Body temperature increased—Triamcinolone—ulcerative colitis	0.000209	0.00249	CcSEcCtD
Albendazole—Abdominal pain—Methylprednisolone—ulcerative colitis	0.000208	0.00248	CcSEcCtD
Albendazole—Hypersensitivity—Hydrocortisone—ulcerative colitis	0.000207	0.00246	CcSEcCtD
Albendazole—Skin disorder—Prednisone—ulcerative colitis	0.000203	0.00241	CcSEcCtD
Albendazole—CYP1A1—Estrogen Receptor Pathway—STAT3—ulcerative colitis	0.000198	0.00635	CbGpPWpGaD
Albendazole—Gastrointestinal pain—Dexamethasone—ulcerative colitis	0.000196	0.00233	CcSEcCtD
Albendazole—Gastrointestinal pain—Betamethasone—ulcerative colitis	0.000196	0.00233	CcSEcCtD
Albendazole—Hypersensitivity—Triamcinolone—ulcerative colitis	0.000195	0.00232	CcSEcCtD
Albendazole—Hypersensitivity—Methylprednisolone—ulcerative colitis	0.000194	0.00231	CcSEcCtD
Albendazole—Urticaria—Dexamethasone—ulcerative colitis	0.00019	0.00227	CcSEcCtD
Albendazole—Urticaria—Betamethasone—ulcerative colitis	0.00019	0.00227	CcSEcCtD
Albendazole—Dizziness—Prednisolone—ulcerative colitis	0.00019	0.00226	CcSEcCtD
Albendazole—Abdominal pain—Dexamethasone—ulcerative colitis	0.000189	0.00226	CcSEcCtD
Albendazole—Abdominal pain—Betamethasone—ulcerative colitis	0.000189	0.00226	CcSEcCtD
Albendazole—Body temperature increased—Dexamethasone—ulcerative colitis	0.000189	0.00226	CcSEcCtD
Albendazole—Body temperature increased—Betamethasone—ulcerative colitis	0.000189	0.00226	CcSEcCtD
Albendazole—Dizziness—Hydrocortisone—ulcerative colitis	0.000185	0.00221	CcSEcCtD
Albendazole—CYP1A2—liver—ulcerative colitis	0.000185	0.0254	CbGeAlD
Albendazole—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—ulcerative colitis	0.000184	0.0059	CbGpPWpGaD
Albendazole—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—ulcerative colitis	0.000184	0.00589	CbGpPWpGaD
Albendazole—CYP1A1—liver—ulcerative colitis	0.000183	0.0251	CbGeAlD
Albendazole—Rash—Prednisolone—ulcerative colitis	0.000181	0.00216	CcSEcCtD
Albendazole—Dermatitis—Prednisolone—ulcerative colitis	0.000181	0.00215	CcSEcCtD
Albendazole—Headache—Prednisolone—ulcerative colitis	0.00018	0.00214	CcSEcCtD
Albendazole—CYP3A4—digestive system—ulcerative colitis	0.00018	0.0247	CbGeAlD
Albendazole—TUBA1A—Metabolism of proteins—MUC2—ulcerative colitis	0.000179	0.00575	CbGpPWpGaD
Albendazole—Vomiting—Hydrocortisone—ulcerative colitis	0.000178	0.00212	CcSEcCtD
Albendazole—Rash—Hydrocortisone—ulcerative colitis	0.000177	0.00211	CcSEcCtD
Albendazole—Dermatitis—Hydrocortisone—ulcerative colitis	0.000177	0.0021	CcSEcCtD
Albendazole—Headache—Hydrocortisone—ulcerative colitis	0.000176	0.00209	CcSEcCtD
Albendazole—Dizziness—Triamcinolone—ulcerative colitis	0.000175	0.00208	CcSEcCtD
Albendazole—Dizziness—Methylprednisolone—ulcerative colitis	0.000174	0.00208	CcSEcCtD
Albendazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000171	0.00549	CbGpPWpGaD
Albendazole—Gastrointestinal pain—Prednisone—ulcerative colitis	0.000171	0.00203	CcSEcCtD
Albendazole—Nausea—Prednisolone—ulcerative colitis	0.000171	0.00203	CcSEcCtD
Albendazole—Vomiting—Triamcinolone—ulcerative colitis	0.000168	0.002	CcSEcCtD
Albendazole—Vomiting—Methylprednisolone—ulcerative colitis	0.000168	0.002	CcSEcCtD
Albendazole—ABCB1—epithelium—ulcerative colitis	0.000167	0.023	CbGeAlD
Albendazole—Nausea—Hydrocortisone—ulcerative colitis	0.000167	0.00198	CcSEcCtD
Albendazole—Rash—Triamcinolone—ulcerative colitis	0.000167	0.00198	CcSEcCtD
Albendazole—Dermatitis—Triamcinolone—ulcerative colitis	0.000166	0.00198	CcSEcCtD
Albendazole—Rash—Methylprednisolone—ulcerative colitis	0.000166	0.00198	CcSEcCtD
Albendazole—Dermatitis—Methylprednisolone—ulcerative colitis	0.000166	0.00198	CcSEcCtD
Albendazole—Urticaria—Prednisone—ulcerative colitis	0.000166	0.00197	CcSEcCtD
Albendazole—Headache—Triamcinolone—ulcerative colitis	0.000165	0.00197	CcSEcCtD
Albendazole—Headache—Methylprednisolone—ulcerative colitis	0.000165	0.00197	CcSEcCtD
Albendazole—Abdominal pain—Prednisone—ulcerative colitis	0.000165	0.00196	CcSEcCtD
Albendazole—Body temperature increased—Prednisone—ulcerative colitis	0.000165	0.00196	CcSEcCtD
Albendazole—ABCB1—HIF-1-alpha transcription factor network—HNF4A—ulcerative colitis	0.000162	0.00519	CbGpPWpGaD
Albendazole—Dizziness—Betamethasone—ulcerative colitis	0.000158	0.00189	CcSEcCtD
Albendazole—Dizziness—Dexamethasone—ulcerative colitis	0.000158	0.00189	CcSEcCtD
Albendazole—CYP1A1—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000158	0.00506	CbGpPWpGaD
Albendazole—TUBB4B—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	0.000157	0.00504	CbGpPWpGaD
Albendazole—TUBB4B—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	0.000157	0.00504	CbGpPWpGaD
Albendazole—Nausea—Triamcinolone—ulcerative colitis	0.000157	0.00187	CcSEcCtD
Albendazole—Nausea—Methylprednisolone—ulcerative colitis	0.000157	0.00186	CcSEcCtD
Albendazole—Hypersensitivity—Prednisone—ulcerative colitis	0.000154	0.00183	CcSEcCtD
Albendazole—Vomiting—Betamethasone—ulcerative colitis	0.000152	0.00181	CcSEcCtD
Albendazole—Vomiting—Dexamethasone—ulcerative colitis	0.000152	0.00181	CcSEcCtD
Albendazole—Rash—Dexamethasone—ulcerative colitis	0.000151	0.0018	CcSEcCtD
Albendazole—Rash—Betamethasone—ulcerative colitis	0.000151	0.0018	CcSEcCtD
Albendazole—Dermatitis—Betamethasone—ulcerative colitis	0.000151	0.0018	CcSEcCtD
Albendazole—Dermatitis—Dexamethasone—ulcerative colitis	0.000151	0.0018	CcSEcCtD
Albendazole—Headache—Betamethasone—ulcerative colitis	0.00015	0.00179	CcSEcCtD
Albendazole—Headache—Dexamethasone—ulcerative colitis	0.00015	0.00179	CcSEcCtD
Albendazole—CYP1A2—Arachidonic acid metabolism—PTGS1—ulcerative colitis	0.000144	0.00461	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—ulcerative colitis	0.000143	0.00458	CbGpPWpGaD
Albendazole—Nausea—Dexamethasone—ulcerative colitis	0.000142	0.0017	CcSEcCtD
Albendazole—Nausea—Betamethasone—ulcerative colitis	0.000142	0.0017	CcSEcCtD
Albendazole—Dizziness—Prednisone—ulcerative colitis	0.000138	0.00164	CcSEcCtD
Albendazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	0.000137	0.00439	CbGpPWpGaD
Albendazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000137	0.00438	CbGpPWpGaD
Albendazole—CYP3A4—liver—ulcerative colitis	0.000134	0.0184	CbGeAlD
Albendazole—Vomiting—Prednisone—ulcerative colitis	0.000133	0.00158	CcSEcCtD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—ulcerative colitis	0.000132	0.00422	CbGpPWpGaD
Albendazole—Rash—Prednisone—ulcerative colitis	0.000132	0.00157	CcSEcCtD
Albendazole—Dermatitis—Prednisone—ulcerative colitis	0.000131	0.00157	CcSEcCtD
Albendazole—Headache—Prednisone—ulcerative colitis	0.000131	0.00156	CcSEcCtD
Albendazole—ABCB1—lymphoid tissue—ulcerative colitis	0.000129	0.0177	CbGeAlD
Albendazole—ABCB1—digestive system—ulcerative colitis	0.000127	0.0175	CbGeAlD
Albendazole—CYP1A2—Estrogen Receptor Pathway—STAT3—ulcerative colitis	0.000126	0.00405	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—IL17A—ulcerative colitis	0.000125	0.004	CbGpPWpGaD
Albendazole—Nausea—Prednisone—ulcerative colitis	0.000124	0.00148	CcSEcCtD
Albendazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	0.000119	0.00383	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—IL12B—ulcerative colitis	0.000116	0.00372	CbGpPWpGaD
Albendazole—CYP1A1—Melatonin metabolism and effects—NFKB1—ulcerative colitis	0.000116	0.00372	CbGpPWpGaD
Albendazole—CYP1A1—Oxidative Stress—NFKB1—ulcerative colitis	0.000113	0.00362	CbGpPWpGaD
Albendazole—TUBA1A—Metabolism of proteins—GHRL—ulcerative colitis	0.000113	0.00361	CbGpPWpGaD
Albendazole—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.000111	0.00356	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—CTLA4—ulcerative colitis	0.000109	0.0035	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—MUC2—ulcerative colitis	0.000108	0.00347	CbGpPWpGaD
Albendazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	0.000106	0.00339	CbGpPWpGaD
Albendazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000106	0.00338	CbGpPWpGaD
Albendazole—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000101	0.00323	CbGpPWpGaD
Albendazole—TUBB4B—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	9.8e-05	0.00314	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—ulcerative colitis	9.64e-05	0.00309	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—HLA-DQA1—ulcerative colitis	9.61e-05	0.00308	CbGpPWpGaD
Albendazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	9.54e-05	0.00306	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor—RELA—ulcerative colitis	9.51e-05	0.00305	CbGpPWpGaD
Albendazole—ABCB1—liver—ulcerative colitis	9.49e-05	0.013	CbGeAlD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—ulcerative colitis	9.24e-05	0.00296	CbGpPWpGaD
Albendazole—CYP1A1—Arachidonic acid metabolism—PTGS2—ulcerative colitis	8.64e-05	0.00277	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—ulcerative colitis	8.6e-05	0.00275	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—ulcerative colitis	8.56e-05	0.00274	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—IL10—ulcerative colitis	8.49e-05	0.00272	CbGpPWpGaD
Albendazole—CYP1A1—Biological oxidations—PTGS1—ulcerative colitis	8.39e-05	0.00269	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	8.11e-05	0.0026	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor—NFKB1—ulcerative colitis	8.02e-05	0.00257	CbGpPWpGaD
Albendazole—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	7.78e-05	0.00249	CbGpPWpGaD
Albendazole—CYP1A2—Melatonin metabolism and effects—NFKB1—ulcerative colitis	7.4e-05	0.00237	CbGpPWpGaD
Albendazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	7.36e-05	0.00236	CbGpPWpGaD
Albendazole—TUBA1A—Metabolism of proteins—MMP1—ulcerative colitis	7.01e-05	0.00225	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	6.92e-05	0.00222	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—HLA-DRB1—ulcerative colitis	6.84e-05	0.00219	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—GHRL—ulcerative colitis	6.81e-05	0.00218	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—ulcerative colitis	6.68e-05	0.00214	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—ulcerative colitis	6.24e-05	0.002	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor—TNF—ulcerative colitis	6.24e-05	0.002	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—ulcerative colitis	6.14e-05	0.00197	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—RELA—ulcerative colitis	6.06e-05	0.00194	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—ulcerative colitis	5.89e-05	0.00189	CbGpPWpGaD
Albendazole—CYP1A1—PPARA activates gene expression—PPARG—ulcerative colitis	5.85e-05	0.00187	CbGpPWpGaD
Albendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—ulcerative colitis	5.72e-05	0.00183	CbGpPWpGaD
Albendazole—TUBB4B—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	5.64e-05	0.00181	CbGpPWpGaD
Albendazole—CYP1A2—Arachidonic acid metabolism—PTGS2—ulcerative colitis	5.51e-05	0.00177	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—ulcerative colitis	5.48e-05	0.00176	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—ulcerative colitis	5.46e-05	0.00175	CbGpPWpGaD
Albendazole—CYP1A2—Biological oxidations—PTGS1—ulcerative colitis	5.35e-05	0.00172	CbGpPWpGaD
Albendazole—TUBB4B—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	5.26e-05	0.00169	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—ulcerative colitis	5.11e-05	0.00164	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—IFNG—ulcerative colitis	4.99e-05	0.0016	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	4.78e-05	0.00153	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	4.78e-05	0.00153	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—CXCL8—ulcerative colitis	4.64e-05	0.00149	CbGpPWpGaD
Albendazole—TUBA1A—Metabolism of proteins—CXCL8—ulcerative colitis	4.51e-05	0.00144	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—IL1B—ulcerative colitis	4.45e-05	0.00143	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—IL2—ulcerative colitis	4.44e-05	0.00142	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—ulcerative colitis	4.26e-05	0.00137	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—MMP1—ulcerative colitis	4.23e-05	0.00136	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—PTGS1—ulcerative colitis	4.13e-05	0.00132	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—ulcerative colitis	3.98e-05	0.00127	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—ulcerative colitis	3.98e-05	0.00127	CbGpPWpGaD
Albendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—ulcerative colitis	3.94e-05	0.00126	CbGpPWpGaD
Albendazole—TUBB4B—Transmembrane transport of small molecules—ALB—ulcerative colitis	3.53e-05	0.00113	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—TGFB1—ulcerative colitis	3.46e-05	0.00111	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CHP1—ulcerative colitis	3.44e-05	0.0011	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle—TP53—ulcerative colitis	3.32e-05	0.00106	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—TNF—ulcerative colitis	3.23e-05	0.00104	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	3.22e-05	0.00103	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	2.98e-05	0.000955	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—DLD—ulcerative colitis	2.97e-05	0.000952	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CHP1—ulcerative colitis	2.75e-05	0.000881	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—CXCL8—ulcerative colitis	2.72e-05	0.000872	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—DLD—ulcerative colitis	2.37e-05	0.00076	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	2.36e-05	0.000757	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CHP1—ulcerative colitis	2.19e-05	0.000703	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	2.06e-05	0.000659	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	2.05e-05	0.000657	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—TP53—ulcerative colitis	2e-05	0.000642	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—DLD—ulcerative colitis	1.89e-05	0.000607	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	1.71e-05	0.000547	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CHP1—ulcerative colitis	1.69e-05	0.000543	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.6e-05	0.000512	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	1.6e-05	0.000511	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.57e-05	0.000503	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—DLD—ulcerative colitis	1.46e-05	0.000468	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PTGS1—ulcerative colitis	1.44e-05	0.00046	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.41e-05	0.000453	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	1.41e-05	0.000451	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CALM3—ulcerative colitis	1.29e-05	0.000414	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.24e-05	0.000396	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PTGS1—ulcerative colitis	1.15e-05	0.000367	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.07e-05	0.000344	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CALM3—ulcerative colitis	1.03e-05	0.000331	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ABCB1—ulcerative colitis	1.01e-05	0.000322	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1e-05	0.000321	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ADCY5—ulcerative colitis	9.38e-06	0.000301	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PTGS1—ulcerative colitis	9.15e-06	0.000293	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	9e-06	0.000289	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CALM3—ulcerative colitis	8.24e-06	0.000264	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	7.88e-06	0.000252	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ADCY5—ulcerative colitis	7.49e-06	0.00024	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PTGS1—ulcerative colitis	7.06e-06	0.000226	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PPARG—ulcerative colitis	6.99e-06	0.000224	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ABCB1—ulcerative colitis	6.41e-06	0.000205	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CALM3—ulcerative colitis	6.36e-06	0.000204	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ALB—ulcerative colitis	6.29e-06	0.000202	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ADCY5—ulcerative colitis	5.98e-06	0.000192	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PPARG—ulcerative colitis	5.59e-06	0.000179	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PTGS2—ulcerative colitis	5.5e-06	0.000176	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ALB—ulcerative colitis	5.02e-06	0.000161	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ABCB1—ulcerative colitis	4.95e-06	0.000159	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ADCY5—ulcerative colitis	4.61e-06	0.000148	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PPARG—ulcerative colitis	4.46e-06	0.000143	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PTGS2—ulcerative colitis	4.39e-06	0.000141	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ALB—ulcerative colitis	4.01e-06	0.000128	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PTGS2—ulcerative colitis	3.51e-06	0.000112	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PPARG—ulcerative colitis	3.44e-06	0.00011	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ALB—ulcerative colitis	3.09e-06	9.92e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PTGS2—ulcerative colitis	2.71e-06	8.68e-05	CbGpPWpGaD
